Duetact Linked to Increased Risk of Bladder Cancer
Duetact, a medication prescribed to treat type 2 diabetes, has been included in a list of pioglitazone-containing medications associated with an increased risk of bladder cancer. The FDA recently released a safety warning stating that taking Duetact or other pioglitazone-containing drugs for over a year is associated with an increased risk of bladder cancer. The FDA is conducting an ongoing safety review of pioglitazone-containing medications as a result of these findings. In addition, the European Medicines Agency is calling for a pan-European study, focused on identifying pioglitazone-associated risks.
Duetact Similar to Actos
Duetact is similar to Actos, which is the brand name for pioglitazone in the U.S. Duetact is a combination of pioglitazone (Actos) and glimepiride, another type of diabetes medication. Glimepiride helps to increase the amount of insulin created by the pancreas, while pioglitazone helps to increase the sensitivity of insulin receptors, combining to help the body respond better to its own insulin and regulate blood sugar levels. Actos and Duetact also carry similar risks and side effects so it is important to be aware of symptoms and speak to a doctor about any medical concerns.
Injured by Duetact? Free and Confidential Consultation.
If you took Duetact and contracted bladder cancer, you may have a legal right to pursue financial compensation for your injuries or other damages. For a free consultation with our Actos lawyers, call toll-free (866) 981-4800 or fill out the form to the right.
Why Girard Gibbs?
Girard Gibbs is a national litigation firm representing consumers, investors, employees, and small businesses in cases involving consumer protection, personal injury, securities, antitrust, and employment laws. The firm’s senior partners, Daniel Girard and Eric Gibbs, have been selected for inclusion in The Best Lawyers in America® 2012 and Northern California Super Lawyers, and have earned AV-Preeminent ratings from Martindale-Hubbell, recognizing them in the highest class of attorneys for professional ethics and legal skills.
